A 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

Olorofim has the potential to be particularly beneficial to patients with hematologic malignancies infected with Invasive ...

Hematology Oncology Associates, a leading cancer treatment center serving Palm Beach County for over 35 years, continues to advance its comprehensive cancer care capabilities through expanded ...

University of Kentucky students celebrated this year’s record-breaking DanceBlue fundraising total of $2,463,650.24, bringing the total to more than $27 million raised since it began in 2006.

Bristol-Myers Squibb's growth portfolio nears 60% of total revenues, growing 16% YoY, effectively offsetting patent cliff ...

Delivering bispecifics and CAR T in community settings could improve access and lower costs but requires robust symptom ...

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

ALBANY - A new child care and early childhood education provider is coming to Albany. The Goddard School, which has ...

In this free webinar, gain insight into new changes in molecular reclassification of hematologic malignancies and their effects in precision medicine. Attendees will learn about the use of molecular ...

Long-term genetic tracking of patients with chronic blood cancers is revealing hidden patterns in how these diseases develop ...

Eli Lilly is in talks to buy Kelonia Therapeutics for $2B+, boosting its oncology pipeline with next-gen CAR-T for multiple ...